Business Context and Reporting Period
Company: Advanced Flower Capital Inc. (AFCG)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: AFC is an institutional lender specializing in senior secured loans to cannabis industry operators and ancillary companies. During the reporting period, the Company operated as a Real Estate Investment Trust (REIT). Effective January 1, 2026, the Company completed a strategic conversion to a Business Development Company (BDC) under the Investment Company Act of 1940, expanding its investment mandate to include a broader universe of lower-middle-market companies outside the cannabis sector.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Interest Income | $24.6 million | $45.7 million |
| Total Expenses | $15.7 million | $17.3 million |
| Provision for Credit Losses | $22.6 million | $4.2 million |
| Net Loss from Continuing Operations | $(20.7) million | $13.9 million |
| Distributable Earnings (Non-GAAP) | $8.7 million | $34.9 million |
| Cash and Cash Equivalents | $38.6 million | $103.6 million |
| Total Debt Outstanding | $98.0 million | $170.0 million |
| Book Value Per Share | $7.46 | $9.02 |
Material Changes vs. Prior Period
- Net Loss vs. Net Income: The Company reported a net loss of $20.7 million in 2025 compared to net income of $13.9 million in 2024. This reversal was primarily driven by a significant increase in the provision for current expected credit losses (CECL) of $22.6 million (up from $4.2 million) and a decrease in interest income.
- Interest Income Decline: Interest income decreased by 39.8% to $31.3 million. This was attributed to loans placed on nonaccrual status (reducing income by $8.3 million), fewer loan exits and prepayments, and lower capital deployment.
- Credit Quality Deterioration: The CECL reserve increased to $46.1 million (18.19% of loans held at carrying value) from $30.6 million (10.36%) in the prior year. Notable write-offs included a $1.8 million equipment loan to Public Company A and a $5.3 million loss on a settlement with Private Company P.
- Stock-Based Compensation: Expenses surged 391.8% to $6.8 million due to the acceleration of restricted stock awards in preparation for the BDC conversion.
- Dividend Reduction: Total dividends declared per share dropped to $0.53 in 2025 from $1.77 in 2024, reflecting the lower earnings and the shift in capital allocation strategy.
Guidance, Outlook, and Risks
Strategic Conversion: The Company has transitioned from a REIT to a BDC effective January 1, 2026. This change removes constraints on real estate collateral coverage, allowing investment in non-real estate assets and a broader range of middle-market companies. The Company intends to elect Regulated Investment Company (RIC) tax status beginning in 2026.
Outlook: Management expects to deploy capital into a diversified portfolio of lower-middle-market companies. As of February 25, 2026, the loan origination pipeline contained approximately $1.4 billion in potential commitments.
Key Risks and Contingencies:
- Cannabis Regulatory Risk: Despite state legalization, cannabis remains illegal under federal law. Changes in federal enforcement or rescheduling (currently under review) could materially impact borrower operations and collateral value.
- Concentration Risk: The portfolio remains concentrated, with the top three borrowers representing approximately 51% of outstanding principal. Subsidiary of Private Company G, a significant borrower, is in default and subject to foreclosure proceedings.
- Liquidity and Funding: The Company relies on a Revolving Credit Facility ($50 million commitment) and Senior Notes ($77 million outstanding). Access to capital markets may be constrained by the Company's association with the cannabis industry.
- Valuation Uncertainty: A significant portion of the portfolio is valued using Level 3 inputs (unobservable data), introducing subjectivity to fair value measurements.
Investor Verification Checklist
- Verify BDC Conversion Status: Confirm the operational and tax implications of the January 1, 2026, conversion to a BDC and the new fee structure under the Advisory Agreement.
- Assess Credit Loss Provisions: Review the specific details of the $22.6 million CECL provision and the status of non-performing loans, particularly the foreclosure proceedings against Subsidiary of Private Company G.
- Monitor Regulatory Developments: Track federal actions regarding cannabis rescheduling and enforcement, as these directly impact the creditworthiness of the core portfolio.
- Review Liquidity Position: Analyze the Company's ability to meet debt service obligations and fund new originations given the reduction in cash reserves from $103.6 million to $38.6 million.
- Examine Related Party Transactions: Scrutinize the terms of the new TCGSL Credit Facility and the Advisory Agreement, noting the significant ownership stake held by the Tannenbaum family in the Manager and affiliates.